Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Advisory Committee Disagreement With US FDA On Approval Decisions An Increasingly Rare Event
Jan 23 2023
•
By
Derrick Gingery
FDA-advisory committee agreement was higher among priority applications compared to standard applications. • Source: Shutterstock
More from US FDA Performance Tracker
More from Regulatory Trackers